,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destinybreast04', 'destiny,breast,4', 'breast']
standing ovation for #destinybreast04 at #asco2022 was incredible! such a practice changing trial! 
Medical Oncologist, Moscow Comprehensive Cancer Centre 62, focused on Breast cancer and Lung cancer